Literature DB >> 27296994

Loss of Notch3 Signaling in Vascular Smooth Muscle Cells Promotes Severe Heart Failure Upon Hypertension.

Hélène Ragot1, Astrid Monfort1, Mathilde Baudet1, Fériel Azibani1, Loubina Fazal1, Régine Merval1, Evelyne Polidano1, Alain Cohen-Solal1, Claude Delcayre1, Nicolas Vodovar1, Christos Chatziantoniou1, Jane-Lise Samuel2.   

Abstract

Hypertension, which is a risk factor of heart failure, provokes adaptive changes at the vasculature and cardiac levels. Notch3 signaling plays an important role in resistance arteries by controlling the maturation of vascular smooth muscle cells. Notch3 deletion is protective in pulmonary hypertension while deleterious in arterial hypertension. Although this latter phenotype was attributed to renal and cardiac alterations, the underlying mechanisms remained unknown. To investigate the role of Notch3 signaling in the cardiac adaptation to hypertension, we used mice with either constitutive Notch3 or smooth muscle cell-specific conditional RBPJκ knockout. At baseline, both genotypes exhibited a cardiac arteriolar rarefaction associated with oxidative stress. In response to angiotensin II-induced hypertension, the heart of Notch3 knockout and SM-RBPJκ knockout mice did not adapt to pressure overload and developed heart failure, which could lead to an early and fatal acute decompensation of heart failure. This cardiac maladaptation was characterized by an absence of media hypertrophy of the media arteries, the transition of smooth muscle cells toward a synthetic phenotype, and an alteration of angiogenic pathways. A subset of mice exhibited an early fatal acute decompensated heart failure, in which the same alterations were observed, although in a more rapid timeframe. Altogether, these observations indicate that Notch3 plays a major role in coronary adaptation to pressure overload. These data also show that the hypertrophy of coronary arterial media on pressure overload is mandatory to initially maintain a normal cardiac function and is regulated by the Notch3/RBPJκ pathway.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  Notch3 signaling; coronary artery; heart failure; hypertension; smooth muscle cells; vasculature

Mesh:

Substances:

Year:  2016        PMID: 27296994     DOI: 10.1161/HYPERTENSIONAHA.116.07694

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  14 in total

1.  Loss of Notch3 Signaling Enhances Osteogenesis of Mesenchymal Stem Cells from Mandibular Torus.

Authors:  X W Dou; W Park; S Lee; Q Z Zhang; L R Carrasco; A D Le
Journal:  J Dent Res       Date:  2016-11-25       Impact factor: 6.116

Review 2.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

Review 3.  Heart failure in diabetes.

Authors:  Stanislovas S Jankauskas; Urna Kansakar; Fahimeh Varzideh; Scott Wilson; Pasquale Mone; Angela Lombardi; Jessica Gambardella; Gaetano Santulli
Journal:  Metabolism       Date:  2021-10-08       Impact factor: 8.694

4.  Notch3 expression in capillary pericytes predicts worse graft outcome in human renal grafts with antibody-mediated rejection.

Authors:  Yichun Xu-Dubois; Panagiotis Kavvadas; Zela Keuylian; Alexandre Hertig; Eric Rondeau; Christos Chatziantoniou
Journal:  J Cell Mol Med       Date:  2022-05-25       Impact factor: 5.295

5.  Computational analysis of the role of mechanosensitive Notch signaling in arterial adaptation to hypertension.

Authors:  Jordy G M van Asten; Tommaso Ristori; David R Nolan; Caitríona Lally; Frank P T Baaijens; Cecilia M Sahlgren; Sandra Loerakker
Journal:  J Mech Behav Biomed Mater       Date:  2022-06-29

6.  Notch3 deficiency impairs coronary microvascular maturation and reduces cardiac recovery after myocardial ischemia.

Authors:  Yong-Kang Tao; Heng Zeng; Guo-Qiang Zhang; Sean T Chen; Xue-Jiao Xie; Xiaochen He; Shuo Wang; Hongyan Wen; Jian-Xiong Chen
Journal:  Int J Cardiol       Date:  2017-01-24       Impact factor: 4.164

Review 7.  The Use of Nutraceuticals to Counteract Atherosclerosis: The Role of the Notch Pathway.

Authors:  Giorgio Aquila; Luisa Marracino; Valeria Martino; Donato Calabria; Gianluca Campo; Cristiana Caliceti; Paola Rizzo
Journal:  Oxid Med Cell Longev       Date:  2019-05-02       Impact factor: 6.543

8.  Role of Notch signaling in neurovascular aging and Alzheimer's disease.

Authors:  Arunima Kapoor; Daniel A Nation
Journal:  Semin Cell Dev Biol       Date:  2020-12-28       Impact factor: 7.499

9.  Biomarkers in patients with heart failure and central sleep apnoea: findings from the SERVE-HF trial.

Authors:  João Pedro Ferreira; Kévin Duarte; Holger Woehrle; Martin R Cowie; Karl Wegscheider; Christiane Angermann; Marie-Pia d'Ortho; Erland Erdmann; Patrick Levy; Anita K Simonds; Virend K Somers; Helmut Teschler; Patrick Rossignol; Wolfgang Koenig; Faiez Zannad
Journal:  ESC Heart Fail       Date:  2020-01-17

Review 10.  Notch3 signalling and vascular remodelling in pulmonary arterial hypertension.

Authors:  Hannah E Morris; Karla B Neves; Augusto C Montezano; Margaret R MacLean; Rhian M Touyz
Journal:  Clin Sci (Lond)       Date:  2019-12-20       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.